The Digital Therapeutics Alliance (DTA) is a global non-profit trade association with the mission of broadening the understanding, adoption, and integration of clinically-validated digital therapeutics into healthcare through education, advocacy, and research.
To facilitate its mission, the Alliance recognizes a group of 2018 Strategic Advisors, from aligned industries beyond its membership, that will engage with DTA leaders and members to establish and progress the Alliance’s goals and initiatives.
Roberto Ascione, founding advisor, welcomes the new member companies Big Health, Kaia Health, Omada Health, Cognoa and Pear Therapeutics and great pharma pioneers Bayer, Merck, Otsuka Pharmaceutical Companies (U.S.) and Sanofi to the DTA family: "Happy to keep supporting DTA alongside all new advisors!"
The Digital Therapeutics Alliance (DTA) was launched in October 2017 through a collaboration of four digital therapeutics companies: Akili Interactive, Propeller Health, Voluntis, and WellDoc. DTA is launched in Europe during Frontiers Health, the premier European health innovation conference being held on November 16t - 17, 2017 in Berlin, Germany.